Structural Heart Imaging Market Overview:
According to the latest report by IMARC Group, titled “Structural Heart Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the global structural heart imaging market. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global structural heart imaging market size reached a value of US$ 16.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 30.4 Billion by 2027 exhibiting a CAGR of 10.60% during 2022-2027.
Structural heart imaging (SHI) refers to an advanced medical technique used for screening and examining the human heart at the molecular level. It utilizes high-resolution cameras to screen the heart and generate detailed images of its interior parts that enable the accurate diagnosis of cardiac conditions. It also assists healthcare professionals during several operative procedures, such as identifying the blockage of blood vessels and locating pathways for insertion to reduce the risk of interference. As a result, SHI techniques are rapidly gaining traction in the healthcare industry for addressing various cardiovascular conditions, including on-valvular and valvular heart diseases.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/structural-heart-imaging-market/requestsample
Structural Heart Imaging Market Trends and Drivers:
The global structural heart imaging market is primarily driven by the rising incidences of congenital heart diseases (CHDs) and lifestyle diseases such as diabetes, obesity, and high blood pressure. Additionally, the surging need for accurate diagnosis and imaging to detect structural heart diseases and the growing awareness regarding cardiac health have catalyzed the SHI demand.
Besides this, the increasing public and private investments for developing advanced SHI and cardiac systems is another major growth-inducing factor. Furthermore, the launch of transcatheter aortic valve replacement (TAVR) for operating heart disease interventions and ensuring instant post-surgery recovery of patients has accelerated the product adoption rate.
Other factors, including the ongoing research and development (R&D) activities, improving healthcare infrastructure, favorable government initiatives, and technological advancements, are also anticipated to catalyze the market growth.
Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/structural-heart-imaging-market
Important Note: If the link is not clickable please open it in a new tab, you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Global Structural Heart Imaging Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- Boston Scientific Corporation
- Circle Cardiovascular Imaging Inc.
- Edwards Lifesciences Corporation
- Integer Holdings Corporation
- Koninklijke Philips N.V.
- Lepu Medical Technology (Beijing) Co. Ltd.
- LivaNova PLC
- Medtronic plc
- Pie Medical Imaging B.V.
- Siemens Healthcare GmbH
The report has segmented the market on the basis of region, imaging modality, procedure type, application and end user.
Breakup by Imaging Modality:
Breakup by Procedure Type:
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Left Atrial Appendage Closure (LAAC)
Market Breakup by Application:
Breakup by End User:
- Specialty Clinics
- Cardiac Centers
- Diagnostic Centers
- Ambulatory Surgical Centers
- Catheterization Laboratories
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800